Browse EX-10 agreements

---

---

---

---

---

---

---

Exhibit 10.1

HIVE DIGITAL TECHNOLOGIES LTD.

(FORMERLY HIVE BLOCKCHAIN TECHNOLOGIES LTD.)

INCENTIVE STOCK OPTION PLAN

Dated:  July 15, 2017

as amended November 16, 2022

---

Table of Contents

ARTICLE 1 DEFINITIONS AND INTERPRETATION	3
1.1  Defined Terms	3
1.2  Interpretation	7
ARTICLE 2 ESTABLISHMENT OF PLAN	7
2.1  Purpose	7
2.2  Shares Reserved	7
2.3  Non-Exclusivity	8
2.4  Effective Date and Term of the Plan	8
ARTICLE 3 ADMINISTRATION OF PLAN	9
3.1  Administration	9
3.2  Amendment, Suspension and Termination	9
3.3  Compliance with Laws	10
3.4  Tax Withholdings	10

…

Exhibit 10.1

	Date:	June 1, 2026

	To:	Live Oak Acquisition Corp. V, a Cayman Islands exempted company (“LOAC”); following the Business Combination (as defined below), to Teamshares Inc., a Delaware corporation, which will result from the redomestication of LOAC to Delaware (collectively, the “Counterparty”).

	Address:	Live Oak Acquisition Corp. V 4921 William Arnold Road Memphis, Tennessee 38117 Attn: Richard Hendrix

	From:	HB Strategies LLC (the “Seller”)

	Re:	Prepaid Share Forward

…

Exhibit 10.1

June 1, 2026

James Levine

San Diego, CA

Dear James,

Offer of Employment with Kazia Therapeutics

On behalf of Kazia Therapeutics, Inc, I am pleased to offer you the position of Chief Financial Officer. We look forward to welcoming you as a colleague.

The terms of the position are as set forth below.

Position

Particulars. Your position, place of work, and commencement date will be as described in Attachment 1 of this letter.

Employer. Your employer will be Kazia Therapeutics, Inc (the “Company”), a Delaware company. Kazia reserves the right to assign your employment to other corporate entities within its group at its sole discretion.

Obligation to Best Efforts. You agree that you will, at all times, loyally and conscientiously perform all the duties and obligations associated with this role to the best of your ability and experience, and to the reasonable satisfaction of the Company.

Outside Activities; Non-Interference; Conflicts of Interest

…

May 27, 2026

James Goren

JAG Multi Investments LLC

c/o Bredefeld & Assoc. PC

125 Maple Avenue, Suite C

Chester, New Jersey 07930

RE:	Demand Notes and Warrants

Dear James

Reference is made to those certain demand notes dated October 21, October 28, November 10, December 13, December 29, 2022, and July 10, 2023 (the “Demand Notes”) issued by INVO Fertility, Inc. (f/k/a INVO Bioscience, Inc.; “INVO”) to JAG Multi Investments LLC (“JAG”). Under the Demand Notes, JAG loaned INVO a total of $600,000. The Demand Notes are currently in payment default and we are entering into this letter agreement (this “Agreement”) to cure such default. All capitalized terms used herein that are not defined shall have the meaning assigned to those terms in the Demand Notes.

By signing below, INVO and JAG agree to the following:

1.	The maturity date of the Demand Notes is extended until December 31, 2026.

…

​

PRIVILEGED AND CONFIDENTIAL

​

April 23, 2026

​

Ericka L. Ayles

2301 Eagle Parkway

Fort Worth, TX 76177

​

**Re:**Amended and Restated Employment Terms

​

Dear Ericka:

​

This amended and restated letter agreement (this “Agreement”) sets forth the terms of your continued employment at Yesway, Inc. (“Yesway,” together with any subsidiaries and affiliates as may employ you from time to time, the “Company”). This Agreement will be effective on the closing date of the initial public offering of Yesway (the “IPO”) or such other date mutually agreed upon by the parties.

​

Employment and Duties

​

You will be employed in the role of Chief Financial Officer and Treasurer of Yesway and you shall perform the duties of this role as are customary and as may be required by the Company. You will report to the CEO of Yesway.

​

…

​

PRIVILEGED AND CONFIDENTIAL

​

April 23, 2026

​

Kurt M. Zernich

2301 Eagle Parkway

Fort Worth, TX 76177

​

**Re:**Amended and Restated Employment Terms

​

Dear Kurt:

​

This amended and restated letter agreement (this “Agreement”) sets forth the terms of your continued employment at Yesway, Inc. (“Yesway,” together with any subsidiaries and affiliates as may employ you from time to time, the “Company”). This Agreement will be effective on the closing date of the initial public offering of Yesway (the “IPO”) or such other date mutually agreed upon by the parties.

​

Employment and Duties

​

You will be employed in the role of General Counsel and Secretary of Yesway and you shall perform the duties of this role as are customary and as may be required by the Company. You will report to the CEO of Yesway.

​

…

YESWAY, INC.

AMENDED AND RESTATED EXECUTIVE SEVERANCE PLAN

1.Establishment and Purpose

This Executive Severance Plan (the “Plan”) was originally established by the Board of Managers of BW Gas & Convenience Holdings, LLC effective as of May 31, 2022 and amended and assumed by Yesway, Inc. (together with its subsidiaries and affiliates that may employ Participants from time to time, the “Company”) as of April 21, 2026 (the “Effective Date”). The purpose of this Plan is to promote the interests of the Company and its equityholders by retaining certain executive-level employees through the provision of severance protections to such employees in the event their employment is terminated under the circumstances described in this Plan. The Plan is intended to be, and shall be interpreted and construed as, an unfunded employee pension benefit plan under Section 3(1) of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”) and Section 2520.104-23 of the regulations promulgated by the U.S. Department of Labor, maintained primarily for the benefit of a select g

…

​

PRIVILEGED AND CONFIDENTIAL

​

April 23, 2026

​

Thomas N. Trkla

2301 Eagle Parkway

Fort Worth, TX 76177

​

**Re:**Amended and Restated Employment Terms

​

Dear Thomas:

​

This amended and restated letter agreement (this “Agreement”) sets forth the terms of your continued employment at Yesway, Inc. (“Yesway,” together with any subsidiaries and affiliates as may employ you from time to time, the “Company”). This Agreement will be effective on the closing date of the initial public offering of Yesway (the “IPO”) or such other date mutually agreed upon by the parties.

​

Employment and Duties

​

You will be employed in the role of President and Chief Executive Officer and you shall perform the duties of this role as are customary and as may be required by the Company. You will report to the Board of Yesway.

​

…

​

Yesway, Inc.

Non-Employee Director Compensation Policy

Non-employee members of the board of directors (the “Board”) of Yesway, Inc. (the “Company”) shall be eligible to receive cash and equity compensation as set forth in this Non-Employee Director Compensation Policy (this “Policy”). The cash and equity compensation described in this Policy shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent (other than, for the avoidance of doubt, Brookwood Financial Partners, LLC or an affiliate thereof) or subsidiary of the Company (each, a “Non-Employee Director”) who may be eligible to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Policy shall become effective after the effectiveness of the Company’s initial public offering (the “IPO”) and shall remain in effect until it is revised or rescinded by further action of the Board. This Polic

…

Signet Jewelers Limited

Second Amended and Restated 2018 Omnibus Incentive Plan

Performance Based Restricted Stock Unit

Award Notice

Grantee:            #ParticipantName#

Grant Date: #GrantDate#

Maximum Achievable Units: Revenue: 200% of Revenue target units

Free Cash Flow: 200% of Free Cash Flow target units

Operating Margin Rate: 200% of Operating Margin Rate target units

Units: Revenue: #VestQuantity1# Free Cash Flow: #VestQuantity2#

Operating Margin Rate: #VestQuantity3#

Performance Cycle: The Performance Cycle for this award is Fiscal Years 2027 through 2029.

Vesting: The Performance Based Restricted Stock Units will vest March 24, 2029 subject to the Committee’s prior certification of performance goals pursuant to Section 2 of the Agreement.

…

SEVENTH AMENDMENT REFINANCING TERM LOANS CUSIP: 58503UAK9

AMENDMENT NO. 7, dated as of May 28, 2026 (this “Amendment”) to the Credit Agreement, dated as of October 21, 2021, among Medline Intermediate, LP, a Delaware limited partnership (“Holdings”), Medline Borrower, LP, a Delaware limited partnership (and successor by merger to Mozart Debt Merger Sub Inc., the “Borrower”), the other Guarantors party thereto from time to time, the lenders and L/C Issuers party thereto from time to time and Bank of America, N.A., as Administrative Agent (in such capacity, the “Administrative Agent”), Collateral Agent, a Lender and an L/C Issuer (as amended by Amendment No. 1 to Credit Agreement, dated as of June 28, 2023, Amendment No. 2 to Credit Agreement, dated as of March 27, 2024, Amendment No. 3 to Credit Agreement, dated as of July 8, 2024, Amendment No. 4 to Credit Agreement, dated as of November 19, 2024, Amendment No. 5 to Credit Agreement, dated as of March 28, 2025, Amendment No. 6 to Credit Agreement, dated as of July 31, 2025, and

…